Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeverfield Regulatory News (SFR)

Share Price Information for Severfield (SFR)

Share Price is delayed by 15 minutes
Get Live Data
27.50    0.05 (0.18%)
Bid:
26.60
Ask:
27.30
Spread: 0.70 (2.632%)
Market Cap: £81.20m
SFR Live PriceLast checked at - London Stock Exchange

Intraday Severfield Share Chart

Directorate Change

16 Oct 2024 14:00

RNS Number : 4684I
Severfield PLC
16 October 2024
 

16 October 2024

Severfield plc

('the Company' or 'the Group')

Directorate Change

Appointment of Cynthia Gordon as Non-Executive Director

Severfield plc, the market leading structural steel group, is pleased to announce the appointment of Cynthia Gordon as a non-executive director with effect from 21st October 2024. She will chair the Company's remuneration committee, taking over from Louise Hardy, who will leave the Board, as previously announced, after a short handover on 31st October. Cynthia will also serve on the Company's nomination and audit committees.

Cynthia is currently a non-executive director and remuneration committee chair at Bodycote plc, the FTSE 250 global industrial services company, non-executive chair of Global Fashion Group, a Luxembourg-based ecommerce company listed in Frankfurt and a non-executive director of Eutelsat Communications SA, a satellite operator listed in Paris. She also acts as a senior advisor to Tillman Global Holdings, an investor in infrastructure businesses and was formerly a non-executive director at Tele2 and Kinnevik.

As an executive director, Cynthia worked at a number of companies, including Millicom, Ooredoo and Orange. She was CEO of Millicom Africa responsible for six countries, and was also Group Commercial Director at Ooredoo, with responsibility for commercial performance across 15 countries.

Charlie Cornish, Non-Executive Chair, commented:

"We are pleased to welcome Cynthia to the Board of Severfield. She brings a wealth of strategic, commercial and operational senior executive experience across different commercial sectors, particularly internationally and is an established non-executive and remuneration committee chair. Her knowledge will be highly beneficial to Severfield as we continue to grow and diversify."

The Company confirms there is no further information to be disclosed for the purposes of UKLR 6.4.8.

 

ENDS

Severfield Alan Dunsmore 01845 577 896

Chief Executive Officer

 

Adam Semple 01845 577 896

Chief Financial Officer

 

Jefferies International Will Soutar 020 7029 8000

 

Panmure Liberum Nicholas How 020 3100 2000

 

Camarco severfield@camarco.co.uk

Ginny Pulbrook 07961 315 138

Tom Huddart 07967 521 573

 

 

 Notes to editors:

Severfield is the UK's market leader in the design, fabrication and construction of structural steel, with a total capacity of c.150,000 tonnes of steel per annum. The Group has seven sites, c.1,900 employees and expertise in large, complex projects across a broad range of sectors. The Group also has an established presence in the expanding Indian market through its joint venture partnership with JSW Steel (India's largest steel producer).

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAQKABQBBDDOKD
Date   Source Headline
22nd Dec 20224:40 pmRNSSecond Price Monitoring Extn
22nd Dec 20224:35 pmRNSPrice Monitoring Extension
13th Dec 20221:14 pmRNSDirector/PDMR Shareholding
2nd Dec 202210:19 amRNSNOTICE OF CHANGE TO DIRECTOR DETAILS
22nd Nov 20227:30 amRNSProgressive publishes new research
22nd Nov 20227:00 amRNSInterim Results
9th Nov 20224:41 pmRNSSecond Price Monitoring Extn
9th Nov 20224:36 pmRNSPrice Monitoring Extension
26th Oct 20227:39 amRNSProgressive publishes new research
17th Oct 20224:36 pmRNSPrice Monitoring Extension
13th Oct 20228:27 amRNSDirector/PDMR Shareholding
3rd Oct 202210:16 amRNSDirectorate Change - Replacement
3rd Oct 20227:00 amRNSDirectorate Change
22nd Sep 20224:41 pmRNSSecond Price Monitoring Extn
22nd Sep 20224:36 pmRNSPrice Monitoring Extension
21st Sep 20224:35 pmRNSPrice Monitoring Extension
8th Sep 202211:44 amRNSResult of AGM
8th Sep 20227:31 amRNSProgressive publishes new research
8th Sep 20227:00 amRNSTrading Statement
8th Aug 202212:00 pmRNSNotice of Annual General Meeting and Annual Report
27th Jul 20222:31 pmRNSHolding(s) in Company
25th Jul 20229:40 amRNSDirector/PDMR Shareholding
13th Jul 202211:26 amRNSDirector/PDMR Shareholding
29th Jun 202212:01 pmRNSDirector/PDMR Shareholding
29th Jun 202212:00 pmRNSDirector/PDMR Shareholding
17th Jun 202210:36 amRNSDirector/PDMR Shareholding
15th Jun 20227:29 amRNSProgressive publishes new research
15th Jun 20227:00 amRNSResults for the year ended 26 March 2022
1st Jun 20229:47 amRNSTotal Voting Rights and Share Capital Update
3rd May 20221:12 pmRNSVoting Rights and Share Capital Update
25th Apr 20225:24 pmRNSHolding(s) in Company
20th Apr 20229:38 amRNSProgressive publishes new research
20th Apr 20227:00 amRNSPre-close Trading Update
5th Apr 20224:22 pmRNSHolding(s) in Company
1st Apr 20222:23 pmRNSVoting Rights and Share Capital Update
18th Mar 20224:35 pmRNSPrice Monitoring Extension
17th Mar 20227:00 amRNSAppointment of Joint Broker
10th Mar 20221:59 pmRNSReplacement - Holding(s) in Company
10th Mar 20227:35 amRNSNotice of Change to Director Details
7th Mar 20226:12 pmRNSHolding(s) in Company
2nd Mar 20224:43 pmRNSVoting Rights and Share Capital Update
2nd Mar 20224:40 pmRNSDirector/PDMR Shareholding
2nd Feb 20229:16 amRNSVoting Rights and Share Capital Update
5th Jan 202211:31 amRNSVoting Rights and Share Capital Update
20th Dec 20214:31 pmRNSCompletion of successful refinancing
9th Dec 20217:59 amRNSNotice of Change to Director Details
7th Dec 20213:31 pmRNSDirector/PDMR Shareholding
23rd Nov 20212:17 pmRNSIssue of Ordinary Shares
23rd Nov 20217:57 amRNSProgressive publishes new research
23rd Nov 20217:01 amRNSInterim Dividend Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.